Medical Affairs Outsourcing Market Report 2026

The medical affairs outsourcing market size has grown rapidly in recent years. It will grow from $2.07 billion in 2025 to $2.3 billion in 2026 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to increasing complexity of regulatory requirements, rising clinical trial volumes, need for specialized medical expertise, cost optimization strategies by pharma companies, expansion of global drug development activities.

The medical affairs outsourcing market size is expected to see rapid growth in the next few years. It will grow to $3.49 billion in 2030 at a compound annual growth rate (CAGR) of 11%. The growth in the forecast period can be attributed to increasing adoption of digital medical affairs solutions, rising demand for real-world evidence generation, growth in biopharmaceutical pipelines, expansion of outsourced msl activities, increasing focus on data-driven medical strategies. Major trends in the forecast period include increasing outsourcing of medical writing functions, rising demand for remote medical monitoring services, growing use of cloud-based medical affairs platforms, expansion of msl outsourcing models, enhanced focus on compliance and regulatory support.

The growing prevalence of infectious diseases is anticipated to drive the expansion of the medical affairs outsourcing market in the coming years. Infectious diseases are caused by pathogens that can spread from one individual to another through various routes, including direct contact, airborne transmission, or vectors. Factors contributing to the rise in infectious diseases include rapid urbanization, lifestyle changes, limited access to healthcare, and environmental factors. Medical affairs outsourcing plays a key role in addressing the surge in infectious diseases by offering expertise in clinical trial management, strengthening regulatory compliance, and enhancing medical communication and information, which supports improved disease management and intervention strategies. For example, in February 2024, the UK Health Security Agency, a governmental department in the UK, reported that tuberculosis (TB) cases in England increased by 10.7%, from 4,380 in 2022 to 4,850 in 2023. Consequently, the rising prevalence of infectious diseases is fueling growth in the medical affairs outsourcing market.

Major companies operating in the medical affairs outsourcing market are emphasizing technological innovations such as artificial intelligence (AI) and technology-enabled solutions to improve data management, streamline clinical trials, and ensure regulatory compliance, ultimately enhancing efficiency and effectiveness in disease management and intervention strategies. Artificial intelligence (AI) and technology-enabled solutions leverage advanced technologies to increase efficiency, accuracy, and decision-making in handling medical data, processes, and interactions. For example, in July 2024, Envision Pharma Group, a UK-based pharmaceutical company, introduced 4Sight Drive, an AI-powered platform that employs machine learning algorithms to identify trends, predict outcomes, and support decision-making within medical affairs. Its distinctive capabilities include processing both structured and unstructured data from various sources, delivering personalized insights for each client, and evolving through user feedback. By utilizing artificial intelligence, organizations can optimize their medical affairs strategies, enhance stakeholder engagement, and improve patient outcomes.

In June 2023, Arterex Medical Inc., a US-based medical device contract manufacturing company, acquired NextPhase Medical Devices LLC for an undisclosed amount. Through this acquisition, Arterex Medical Inc. aims to strengthen its multi-capability platform, expand manufacturing and assembly capacities, and broaden its customer base across North America and Europe. NextPhase Medical Devices LLC is a US-based medical device contract manufacturing company specializing in medical affairs outsourcing.

Major companies operating in the medical affairs outsourcing market are IQVIA Holdings Inc., ICON plc, Syneos Health Inc., PAREXEL International Corporation, Charles River Laboratories International Inc., Medpace Holdings Inc., Indegene Inc., Caidya Inc., Cytel Inc., Alira Health Inc., The Medical Affairs Company LLC, Bioscript Group Limited, ProPharma Group, EVERSANA, PharmaLex Group, ClinChoice, Astrix, Kantar Health, Precision Medicine Group, Envision Pharma Group.

North America was the largest region in the medical affairs outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical affairs outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical affairs outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are indirectly impacting the medical affairs outsourcing market by increasing costs associated with imported IT infrastructure, cloud hosting services, secure data management systems, and analytics tools used by service providers. Pharmaceutical and biopharmaceutical companies in North America and Europe are most affected due to reliance on global software vendors, while Asia-Pacific faces higher operational costs for cross-border service delivery. These tariffs are raising service pricing and contract costs. However, they are also driving regionalization of service hubs, increased use of locally hosted platforms, and investments in domestic medical affairs capabilities.

The medical affairs outsourcing market research report is one of a series of new reports that provides medical affairs outsourcing market statistics, including medical affairs outsourcing industry global market size, regional shares, competitors with a medical affairs outsourcing market share, detailed medical affairs outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the medical affairs outsourcing industry. This medical affairs outsourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical affairs outsourcing involves engaging external firms or professionals to manage specific medical affairs functions within an organization. By outsourcing these activities, companies can gain access to specialized knowledge, control expenses, and concentrate on their primary business operations. Organizations may partner with contract research organizations (CROs), medical communication agencies, or other expert service providers for these services.

The key areas of medical affairs outsourcing include medical writing and publishing, medical monitoring, medical science liaisons (MSLs), medical information, and additional services. Medical writing and publishing entails preparing and distributing scientific documents, such as clinical trial reports, regulatory submissions, and research articles, to convey medical and scientific information accurately and effectively. The tools employed in these tasks include cloud-based and on-premise software. These services are applied across industries like pharmaceuticals, biopharmaceuticals, and medical devices.

The medical affairs outsourcing market includes revenues earned by entities by providing services such as regulatory affairs, medical information services, clinical trial support, pharmacovigilance, medical writing, key opinion leader (KOL) management, market access support, and training and education. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.